Search Results - "Waratkar, Gopichand"
-
1
Long term outcomes of a randomized controlled clinical trial comparing the efficacy of Cabazitaxel versus docetaxel as second-line or above therapy in recurrent head and neck cancer
Published in Oral oncology (01-11-2022)“…•Cabazitaxel had inferior PFS in comparison to docetaxel.•Cabazitaxel has inferior OS in comparison to docetaxel.•Age and site of disease influence OS…”
Get full text
Journal Article -
2
Long term toxicity and tolerance of concurrent docetaxel with radiotherapy in cisplatin-ineligible head and neck cancer patients
Published in Oral oncology (01-07-2022)Get full text
Journal Article